Huawei Showcases Watch D3 and 2-Study Terve Platform to Push Wearables Into Digital Health
Updated
Updated · Total Telecom · Sep 9
Huawei Showcases Watch D3 and 2-Study Terve Platform to Push Wearables Into Digital Health
2 articles · Updated · Total Telecom · Sep 9
Summary
Munich event showcased Huawei’s Watch D3 alongside Terve Research, a new European platform that lets medical and academic institutions run wearable-based studies and recruit opt-in Huawei users.
Watch D3 centers on blood-pressure monitoring, pairing four daytime and three nighttime micro-pump readings with continuous PPG trend tracking to reduce the disruption of repeated cuff inflations.
The device is 17.7% thinner and 9% lighter than its predecessor and has CE medical-device certification for resting blood pressure, 24-hour ABPM and pre- and post-exercise measurement.
Terve launches with 2 studies—on social jetlag and on exercise patterns versus cardiovascular risk—and is funded by Huawei but independently operated by medical technology provider Thryve.
Huawei is using that research layer to differentiate beyond basic fitness tracking, extending a health ecosystem that it says already includes 160-plus healthcare institutions and more than 10 research centres globally.